1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Chlamydia Infection Diagnostics and Therapeutics Market

Chlamydia Infection Diagnostics and Therapeutics Sector Analysis, Projection in the coming years

  • June 2017
  • 211 pages
  • ID: 4977668
In this report:
Table ##: Incidence rates (per ##,##) by infection and sex, based on 2005 to 2012 data (##% uncertainty interval shown in parentheses)
Table ##: Percentage of population (%) with prevalent infection in 2012 by infection and sex (##% uncertainty interval shown in parentheses)
Market related factors such as global incidence/prevalence of sexual transmitted infection, global incidence/prevalence of eye infection, cost of sexual transmitted infection in U.S (2010-2015), and historical year-on-year growth have been taken into consideration while estimating the market size.

Summary

Table of Contents

Global Chlamydia Infection Diagnostics and Therapeutics Market: Summary

Chlamydial infection, caused by Chlamydia trachomatis, is the most frequent contagious sexually transmitted infection and results in meaningful economic cost and morbidity worldwide. Occurs most commonly in young sexually active population, C. trachomatis causes urethritis in men and cervicitis in women, as well as extra-genital infections, including pharyngeal and rectal infections. Asymptomatic infections are frequent in both men and women. Untreated chlamydial infection may cause severe abnormalities related with the upper reproductive tract, primarily in younger women, including salpingitis, infertility, and ectopic pregnancy. Maternal infection is associated with serious adverse results in neonates, including low birth weight, preterm birth, nasopharyngeal infection, chlamydial conjunctivitis, and pneumonia. C. trachomatis can be diagnosed by culture, Nucleic Acid Amplification Tests, Direct Fluorescent Tests, and others.

Global Chlamydia Infection Diagnostics and Therapeutics Market: Scope

This industry report on the overall chlamydia infection diagnostics and therapeutics market examines the current and future prospects of the market. The markets of diagnostics and therapeutics are independently analyzed as two separate markets within the industry report. The industry for chlamydia infection therapeutics is broken down based on product variety, consuemr and region, while the sector for chlamydia infection diagnostics is split based on diagnostics and consuemr. The study comprises a detailed executive summary, containing a market snapshot that offers global information of several segments and subsegments. The industry research is a combination of primary and secondary research. A in-depth qualitative analysis of factors responsible for driving and restraining market increase and alternatives has been specified in the market survey part. Market income in terms of US$ Mn for the time between 2015 and 2025 along with the CAGR from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market related factors including overall incidence/prevalence of sexual transmitted infection, overall incidence/prevalence of eye infection, cost of sexual transmitted infection in U.S (2010-2015), and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each division within the overall chlamydia infection diagnostics and therapeutics market have been determined after a thorough analysis of past trends, demographics, next trends, technological developments, clinical trials, and regulatory requirements. These aspects would benefit the key market players to take tactical decisions in order to enhance their positions and expand their share in the overall market.

Global Chlamydia Infection Diagnostics and Therapeutics Market: Segmentation

Established on product class, the overall chlamydia infection diagnostics and therapeutics market has been divided into diagnostics and therapeutics. Chlamydia infection diagnostics segment further broken down into nucleic acid amplification tests, direct fluorescent tests, and others.

The therapeutics used for treatment of chlamydia infection contain Macrolides, Quinolones, Sulfonamides, Tetracycline, and Aminopenicillins. Macrolides are the antibiotics most commonly prescribed to treat chlamydia infection.

Geographically, the overall chlamydia infection diagnostics and therapeutics market has been split into five regions: North America continent, Europe (EU), Asia Pacific (APAC), Latin America area, and Middle East (ME) & African continent. Additionally, the areas have been farther divided by main countries for the chlamydia infection therapeutics market. These include the U.S.A, Canada (CA), Germany (DE), France (FR), Spain (ES), Italy (IT), U.K., Russia, China (CN), Japan (JP), India (IN), Brazil (BR), Mexico (MX), GCC countries, and South Africa (ZA). The competition matrix section included in the analysis is likely to assist the existing players to increase their market shares and additional companies to establish their presence in the overall chlamydia infection diagnostics and therapeutics market. The study also describes main actors in the chlamydia infection diagnostics and therapeutics segment based on several features such as corporate overview and financial analysis, SWOT study, main business strategies, product portfolio, and recent evolutions. Key companies decribed in the market research contain Bio Rad laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher, bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Organization

The overall chlamydia infection therapeutics and diagnostics segment has been split as follows:

Overall Chlamydia Infection Diagnostics Market, by Product

Overall Chlamydia Infection Diagnostics Market, by End-user

Overall Chlamydia Infection Diagnostics and Therapeutics Market, by Geography

North America (NA)

USA

Canada (CA)

Europe (EU)

Germany (DE)

France (FR)

Spain (ES)

Italy (IT)

United Kingdom (UK)

Russia (RU)

Rest of europe (EU)

Asia-Pac

Japan (JP)

China (CN)

India (IN)

Rest of Asia-Pac

Latin America

Brazil (BR)

Mexico (MX)

Rest of Latin America

African region & Middle East

South africa (SA)

GCC Countries

Rest of middle east and African regions (MEA)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

  • $ 2000
  • October 2018

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated ...

Clinical Research in Vaginal Cancer in H2, 2018

Clinical Research in Vaginal Cancer in H2, 2018

  • $ 2500
  • September 2018

Vaginal Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Vaginal Cancer clinical ...

2019-2023 Europe Sexually-Transmitted Diseases Diagnostics Market: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers

2019-2023 Europe Sexually-Transmitted Diseases Diagnostics Market: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers

  • $ 3450
  • December 2018

2019-2023 Europe Sexually-Transmitted Diseases (STD) Diagnostics Market: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on